Gender differences in esophageal variceal bleeding in the United States
- PMID: 35930410
- PMCID: PMC9359179
- DOI: 10.1080/07853890.2022.2104920
Gender differences in esophageal variceal bleeding in the United States
Abstract
Background and aims: Esophageal variceal bleeding is a common reason for hospitalization in patients with cirrhosis. The main objective of this study was to analyze the effects of gender differences on outcomes in hospitalizations related to Esophageal variceal bleeding in the United States.
Methods: A retrospective observational cohort study was performed using the National Inpatient Sample (NIS) database for all hospitalizations with a discharge diagnosis of esophageal varices with hemorrhage from 2016 to 2019. The primary outcome was in-hospital mortality, while secondary outcomes included rate of early endoscopy (defined as less than 1 day), AKI, blood transfusion, sepsis, ICU admission and TIPS (Transjugular Intrahepatic Portosystemic Shunt). We also compared the length of stay and total hospitalization charges.
Results: We identified a total of 166,760 patients with variceal bleeding of which 32.7% were females. In-hospital mortality was higher in males, 9.91%, compared to females, 8.31% (adjusted odds ratio (aOR): 0.88, p-value=.008, when adjusted for confounding factors). The odds of undergoing an EGD, length of stay, or total hospitalization charges did not differ between the two groups. Compared to men, women had lower odds of receiving TIPS (aOR = 0.83, p-value=.002).
Conclusion: Women hospitalised with esophageal variceal bleeding are at a lower risk of death compared to males. Further research is needed to elucidate the factors associated with this lower risk.
Keywords: Gender; cirrhosis; disparities; variceal bleeding.
Conflict of interest statement
No potential conflict of interest was reported by the authors.
Figures
Similar articles
-
High Prevalence of Transjugular Intrahepatic Portosystemic Shunt Creation Without Prior Endoscopy During Acute Variceal Bleeding Hospitalization in the United States.Hepatol Commun. 2021 Oct;5(10):1784-1790. doi: 10.1002/hep4.1756. Epub 2021 Jul 1. Hepatol Commun. 2021. PMID: 34558832 Free PMC article.
-
Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.J Gastroenterol Hepatol. 2017 Apr;32(4):852-858. doi: 10.1111/jgh.13593. J Gastroenterol Hepatol. 2017. PMID: 27624167 Free PMC article.
-
[Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in liver cirrhosis: intended population and timing].Zhonghua Gan Zang Bing Za Zhi. 2017 Jun 20;25(6):402-407. doi: 10.3760/cma.j.issn.1007-3418.2017.06.002. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 28763854 Review. Chinese.
-
Combined Use of Transjugular Intrahepatic Portosystemic Shunt and Transarterial Chemoembolization in the Treatment of Esophageal and Gastric Variceal Bleeding: A Retrospective Study of 80 Patients with Hepatocellular Carcinoma and Portal Hypertension.Med Sci Monit. 2021 Nov 29;27:e934436. doi: 10.12659/MSM.934436. Med Sci Monit. 2021. PMID: 34840325 Free PMC article.
-
Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleeding.Curr Med Res Opin. 2016;32(3):467-75. doi: 10.1185/03007995.2015.1124846. Epub 2016 Jan 25. Curr Med Res Opin. 2016. PMID: 26804426 Review.
Cited by
-
Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions.World J Gastroenterol. 2022 Nov 7;28(41):5910-5930. doi: 10.3748/wjg.v28.i41.5910. World J Gastroenterol. 2022. PMID: 36405106 Free PMC article. Review.
-
Identification of multiple complications as independent risk factors associated with 1-, 3-, and 5-year mortality in hepatitis B-associated cirrhosis patients.BMC Infect Dis. 2025 Feb 1;25(1):151. doi: 10.1186/s12879-025-10566-6. BMC Infect Dis. 2025. PMID: 39891059 Free PMC article.
-
Frailty as a risk-stratification tool in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS).J Frailty Sarcopenia Falls. 2023 Jun 1;8(2):83-93. doi: 10.22540/JFSF-08-083. eCollection 2023 Jun. J Frailty Sarcopenia Falls. 2023. PMID: 37275658 Free PMC article.
-
Outcomes among patients with hepatorenal syndrome based on hospital teaching and transplant status: Analysis of 159 845 hospitalizations.JGH Open. 2023 Nov 27;7(12):848-854. doi: 10.1002/jgh3.12985. eCollection 2023 Dec. JGH Open. 2023. PMID: 38162842 Free PMC article.
-
Acute Variceal Hemorrhage in Germany-A Nationwide Study of 65,357 Hospitalized Cases: Variceal Hemorrhage in Germany.Can J Gastroenterol Hepatol. 2024 Oct 24;2024:5453294. doi: 10.1155/2024/5453294. eCollection 2024. Can J Gastroenterol Hepatol. 2024. PMID: 39483247 Free PMC article.
References
-
- Kim WR, Brown RS, Terrault NA, et al. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002;36(1)In :227–242. - PubMed
-
- Ratib S, West J, Crooks CJ, et al. Diagnosis of liver cirrhosis in England, a cohort study, 1998–2009: a comparison with cancer. Am J Gastroenterol. 2014;109(2):190–198. - PubMed
-
- Lonardo A, Bellentani S, Argo CK, Non-alcoholic Fatty Liver Disease Study Group, et al. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Dig Liver Dis. 2015;47(12):997–1006. - PubMed
-
- Scaglione S, Kliethermes S, Cao G, et al. The epidemiology of cirrhosis in the United States: a population-based study. J Clin Gastroenterol. 2015;49(8):690–696. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources